Stocks
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
| EV/EBITDA | ? | 15.1 | -8.51 | -3.45 | -12.0 | 277.4 | -25.4 | |
| Changes by years, y/y, % | -259% | -156% | -59% | +248% | -2 410% | |||
Blueprint Medicines Corporation. EV/EBITDA
Blueprint Medicines Corporation. EV/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| EV/EBITDA | ? | -25.8 | -48.5 | -97.9 | 280.8 | -39.5 | -25.4 | |
| Changes by years, y/y, % | +628% | +660% | +1 905% | -2 301% | +53% | |||
| Changes by quarters, q/q, % | +102% | +88% | +102% | -387% | -114% | |||
